InterCure Ltd. (INCR) vs MiNK Therapeutics, Inc. (INKT)

A side-by-side comparison of InterCure Ltd. and MiNK Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

INCR

InterCure Ltd.

$65M

$5.46HealthcareDelayed quote: Oct 6, 2026, 10:27 AM EDT

INKT

MiNK Therapeutics, Inc.

$59M

$11.75HealthcareDelayed quote: Oct 6, 2026, 10:29 AM EDT

Total return — INCR vs INKT

growth of $100 · dividends reinvested · last 5y

INCR -84.6% (-31.2%/yr)INKT -89.8% (-36.7%/yr)INCR compounded faster over this window

INCR INKT

INCR vs INKT: by the numbers

•INCR is the larger company ($65M vs $59M market cap).
•Both run net losses; INKT's is the smaller (0.00% vs -13.72% net margin).

Metrics side by side

Valuation

Metric	INCR	INKT
P/S ratio	0.81	N/A
P/B ratio	0.52	N/A
FCF yield	11.37%	N/A

Profitability

Metric	INCR	INKT
Gross margin	14.40%	0.00%
Operating margin	2.49%	0.00%
Net margin	-13.72%	0.00%
ROE	-8.80%	N/A
ROIC	-4.72%	-604.20%

Growth (annualized)

Metric	INCR	INKT
Revenue CAGR (5Y)	32.71%	N/A
Total return CAGR (5Y)	-30.85%	N/A

Go deeper

Full INCR analysis Full INKT analysis Interactive comparison tool

Dig into the metrics

InterCure ROE MiNK Therapeutics ROE InterCure operating margin MiNK Therapeutics operating margin InterCure revenue growth MiNK Therapeutics revenue growth InterCure free cash flow MiNK Therapeutics free cash flow

InterCure & MiNK Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.